| 1 | Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion | 8.8 | 5 | Citations (PDF) |
| 2 | Holistic acceptability of an adult levofloxacin formulation in children and adolescents on a tuberculosis preventive treatment trial | 2.2 | 0 | Citations (PDF) |
| 3 | Tuberculosis in children and adolescents: a forgotten group in a forgotten disease 2023, , | | 1 | Citations (PDF) |
| 4 | The Impact of Hyponatremia on the Severity of Childhood Tuberculous Meningitis | 2.5 | 2 | Citations (PDF) |
| 5 | The Diagnostic Accuracy of Chest Radiographic Features for Pediatric Intrathoracic Tuberculosis | 5.6 | 9 | Citations (PDF) |
| 6 | Household contact investigation for the detection of active tuberculosis and latent tuberculosis: A comprehensive evaluation in two high-burden provinces in Iran | 1.7 | 5 | Citations (PDF) |
| 7 | Drug concentration at the site of disease in children with pulmonary tuberculosis | 3.2 | 3 | Citations (PDF) |
| 8 | Tuberculous Meningitis in Children: A Forgotten Public Health Emergency | 2.5 | 7 | Citations (PDF) |
| 9 | Diagnostic Challenges in Childhood Pulmonary Tuberculosis—Optimizing the Clinical Approach | 3.1 | 16 | Citations (PDF) |
| 10 | Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children | 25.5 | 113 | Citations (PDF) |
| 11 | Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability | 3.1 | 26 | Citations (PDF) |
| 12 | Update on the Treatment of Pediatric Tuberculous Meningitis | 1.3 | 4 | Citations (PDF) |
| 13 | The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study | 13.9 | 21 | Citations (PDF) |
| 14 | Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children | 2.5 | 4 | Citations (PDF) |
| 15 | Transcriptomics for child and adolescent tuberculosis* | 6.8 | 25 | Citations (PDF) |
| 16 | Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review | 1.4 | 2 | Citations (PDF) |
| 17 | Toward a conceptual framework of the acceptability of tuberculosis treatment in children using a theory generative approach | 2.2 | 4 | Citations (PDF) |
| 18 | Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa | 5.6 | 38 | Citations (PDF) |
| 19 | Thalidomide Use for Complicated Central Nervous System Tuberculosis in Children: Insights From an Observational Cohort | 5.6 | 32 | Citations (PDF) |
| 20 | Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment | 2.5 | 21 | Citations (PDF) |
| 21 | Development of a Treatment-decision Algorithm for Human Immunodeficiency Virus–uninfected Children Evaluated for Pulmonary Tuberculosis | 5.6 | 20 | Citations (PDF) |
| 22 | The Impact of the Evolving Human Immunodeficiency Virus Response on the Epidemiology of Tuberculosis in South African Children and Adolescents | 5.6 | 5 | Citations (PDF) |
| 23 | Mortality in South African Children and Adolescents Routinely Treated for Tuberculosis | 4.1 | 16 | Citations (PDF) |
| 24 | Paediatric tuberculosis – new advances to close persistent gaps | 2.2 | 25 | Citations (PDF) |
| 25 | Risk factors for ischemic stroke in children with tuberculous meningitis | 1.0 | 11 | Citations (PDF) |
| 26 | Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis | 2.5 | 6 | Citations (PDF) |
| 27 | Defeating Paediatric Tuberculous Meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap” | 4.0 | 12 | Citations (PDF) |
| 28 | Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe | 7.7 | 16 | Citations (PDF) |
| 29 | Quantifying the global number of tuberculosis survivors: a modelling study | 15.7 | 78 | Citations (PDF) |
| 30 | Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register | 3.7 | 9 | Citations (PDF) |
| 31 | The use of thalidomide to treat children with tuberculosis meningitis: A review | 2.0 | 19 | Citations (PDF) |
| 32 | Childhood Tuberculosis 2021, , 229-243 | | 0 | Citations (PDF) |
| 33 | Concordance of Drug-resistance Profiles Between Persons With Drug-resistant Tuberculosis and Their Household Contacts: A Systematic Review and Meta-analysis | 5.6 | 15 | Citations (PDF) |
| 34 | Tuberculosis in Children and Adolescents 2021, , 115-141 | | 0 | Citations (PDF) |
| 35 | Management of tuberculous meningitis in children | 1.1 | 5 | Citations (PDF) |
| 36 | The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults | 3.1 | 16 | Citations (PDF) |
| 37 | Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward | 4.5 | 10 | Citations (PDF) |
| 38 | The global burden of tuberculous meningitis in adults: A modelling study | 2.2 | 45 | Citations (PDF) |
| 39 | Using Changes in Weight-for-Age z Score to Predict Effectiveness of Childhood Tuberculosis Therapy | 1.5 | 5 | Citations (PDF) |
| 40 | European guidance on drug-resistant tuberculosis in children and adolescents | 7.7 | 3 | Citations (PDF) |
| 41 | Abdominal Tuberculosis in Children: Challenges, Uncertainty, and Confusion | 1.5 | 28 | Citations (PDF) |
| 42 | Adolescent tuberculosis | 7.7 | 104 | Citations (PDF) |
| 43 | International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines | 0.8 | 6 | Citations (PDF) |
| 44 | Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease | 25.5 | 125 | Citations (PDF) |
| 45 | Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study | 13.9 | 12 | Citations (PDF) |
| 46 | Access to paediatric formulations for the treatment of childhood tuberculosis | 7.7 | 8 | Citations (PDF) |
| 47 | Abdominal Involvement in Children With Bacteriologically Confirmed Tuberculosis | 1.3 | 6 | Citations (PDF) |
| 48 | Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children | 1.3 | 12 | Citations (PDF) |
| 49 | Protecting children in low-income and middle-income countries from COVID-19 | 4.2 | 26 | Citations (PDF) |
| 50 | Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward | 5.6 | 31 | Citations (PDF) |
| 51 | The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis | 35.3 | 185 | Citations (PDF) |
| 52 | Preventing tuberculosis in children: A global health emergency | 1.3 | 10 | Citations (PDF) |
| 53 | Decision-making in the diagnosis of tuberculous meningitis | 1.0 | 12 | Citations (PDF) |
| 54 | Opportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa | 5.5 | 10 | Citations (PDF) |
| 55 | The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis | 22.1 | 89 | Citations (PDF) |
| 56 | The evolving research agenda for paediatric tuberculosis infection | 15.7 | 19 | Citations (PDF) |
| 57 | Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children | 1.9 | 35 | Citations (PDF) |
| 58 | Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis | 1.3 | 12 | Citations (PDF) |
| 59 | Building a tuberculosis-free world: The Lancet Commission on tuberculosis | 35.3 | 263 | Citations (PDF) |
| 60 | Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis | 4.0 | 17 | Citations (PDF) |
| 61 | The STREAM trial: missed opportunities and lessons for future clinical trials | 15.7 | 7 | Citations (PDF) |
| 62 | The Changing Landscape of Childhood Tuberculosis in the United Kingdom | 1.3 | 4 | Citations (PDF) |
| 63 | Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection | 9.7 | 20 | Citations (PDF) |
| 64 | Tuberculosis susceptibility and protection in children | 15.7 | 89 | Citations (PDF) |
| 65 | The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes | 1.0 | 77 | Citations (PDF) |
| 66 | Knowledge gaps and research priorities in tuberculous meningitis | 1.0 | 14 | Citations (PDF) |
| 67 | Tuberculous meningitis: new tools and new approaches required | 1.0 | 10 | Citations (PDF) |
| 68 | Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children | 2.9 | 17 | Citations (PDF) |
| 69 | Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover Trial | 1.3 | 8 | Citations (PDF) |
| 70 | Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study | 9.7 | 11 | Citations (PDF) |
| 71 | The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis? | 5.0 | 69 | Citations (PDF) |
| 72 | Treatment of Multidrug-Resistant Tuberculosis Infection in Children | 1.3 | 8 | Citations (PDF) |
| 73 | Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study | 13.9 | 55 | Citations (PDF) |
| 74 | Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis | 22.1 | 20 | Citations (PDF) |
| 75 | Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis | 8.1 | 104 | Citations (PDF) |
| 76 | Treatment of Multidrug-resistant Tuberculosis Infection in Children | 1.3 | 11 | Citations (PDF) |
| 77 | Challenges in childhood tuberculosis 2018, , | | 3 | Citations (PDF) |
| 78 | The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis | 4.8 | 72 | Citations (PDF) |
| 79 | Linezolid for Children With Tuberculous Meningitis | 1.3 | 1 | Citations (PDF) |
| 80 | <i>Mycobacterium tuberculosis</i>transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis | 7.7 | 14 | Citations (PDF) |
| 81 | Prevention of hearing loss in patients with multidrug-resistant tuberculosis | 35.3 | 4 | Citations (PDF) |
| 82 | The global burden of tuberculosis mortality in children: a mathematical modelling study | 13.9 | 273 | Citations (PDF) |
| 83 | Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa | 5.6 | 32 | Citations (PDF) |
| 84 | Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature | 2.7 | 22 | Citations (PDF) |
| 85 | New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations | 9.7 | 60 | Citations (PDF) |
| 86 | Reply to Raoult | 5.6 | 4 | Citations (PDF) |
| 87 | Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis | 4.0 | 44 | Citations (PDF) |
| 88 | If you look, you will find: time to challenge the childhood tuberculosis paradigm | 1.2 | 0 | Citations (PDF) |
| 89 | The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study | 2.7 | 11 | Citations (PDF) |
| 90 | Homeless shelter context and tuberculosis illness experiences during a large outbreak in Atlanta, Georgia | 1.2 | 1 | Citations (PDF) |
| 91 | The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection | 4.8 | 59 | Citations (PDF) |
| 92 | Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis | 5.2 | 18 | Citations (PDF) |
| 93 | Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis | 3.6 | 6 | Citations (PDF) |
| 94 | Interrupted BCG vaccination is a major threat to global child health | 22.1 | 27 | Citations (PDF) |
| 95 | Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study | 7.7 | 6 | Citations (PDF) |
| 96 | Harnessing Novel Quantitative Pharmacology Approaches to Optimize the Treatment of Children With Tuberculosis | 5.6 | 3 | Citations (PDF) |
| 97 | Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis,<i>Sui Generis</i>: The Road Ahead | 5.6 | 7 | Citations (PDF) |
| 98 | Two sizes do not fit all: the terms infection and disease are inadequate for the description of children with tuberculosis | 1.6 | 2 | Citations (PDF) |
| 99 | Global burden of drug-resistant tuberculosis in children: a mathematical modelling study | 15.7 | 179 | Citations (PDF) |
| 100 | Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China | 7.7 | 9 | Citations (PDF) |
| 101 | GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last | 5.6 | 100 | Citations (PDF) |
| 102 | Childhood TB: can the End TB Strategy deliver? | 1.4 | 7 | Citations (PDF) |
| 103 | HIV and tuberculosis in children: biology meets epidemiology | 8.2 | 1 | Citations (PDF) |
| 104 | Time to be a bit more ‘surgical' in our management of children with drug-resistant tuberculosis | 1.2 | 4 | Citations (PDF) |
| 105 | Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen | 4.0 | 8 | Citations (PDF) |
| 106 | Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children | 5.6 | 7 | Citations (PDF) |
| 107 | Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis | 4.3 | 18 | Citations (PDF) |
| 108 | The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa | 3.3 | 11 | Citations (PDF) |
| 109 | A systematic review and meta-analysis of the efficacy and safety of<i>N</i>-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB | 4.8 | 56 | Citations (PDF) |
| 110 | Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment | 35.3 | 144 | Citations (PDF) |
| 111 | Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe | 2.5 | 31 | Citations (PDF) |
| 112 | Epidemiology and disease burden of tuberculosis in children: a global perspective | 2.6 | 99 | Citations (PDF) |
| 113 | Managing multidrug-resistant tuberculosis in children | 3.5 | 22 | Citations (PDF) |
| 114 | High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study | 4.8 | 92 | Citations (PDF) |
| 115 | Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study | 13.9 | 299 | Citations (PDF) |
| 116 | Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study | 2.7 | 33 | Citations (PDF) |
| 117 | Toxicity and Tolerability of Fluoroquinolone-based Preventive Therapy for Childhood Contacts of Multidrug-resistant Tuberculosis | 1.3 | 6 | Citations (PDF) |
| 118 | Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study | 2.7 | 24 | Citations (PDF) |
| 119 | Hearing loss in children treated for multidrug-resistant tuberculosis | 2.9 | 71 | Citations (PDF) |
| 120 | Retooling Existing Tuberculosis Drugs for Children | 5.6 | 5 | Citations (PDF) |
| 121 | Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children | 1.5 | 40 | Citations (PDF) |
| 122 | Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study | 5.6 | 97 | Citations (PDF) |
| 123 | Hearing loss in patients on treatment for drug-resistant tuberculosis | 7.7 | 94 | Citations (PDF) |
| 124 | Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and Outcome | 5.6 | 87 | Citations (PDF) |
| 125 | Multidrug-Resistant Tuberculosis of the Spine in Children--Characteristics from a High Burden Setting | 1.1 | 13 | Citations (PDF) |
| 126 | Impact of Drug Resistance on Clinical Outcome in Children With Tuberculous Meningitis | 1.3 | 45 | Citations (PDF) |
| 127 | Discordant Drug Susceptibility For Mycobacterium tuberculosis within Families | 1.3 | 3 | Citations (PDF) |
| 128 | Epidemiology and management of childhood multidrug-resistant tuberculosis | 0.0 | 1 | Citations (PDF) |
| 129 | Caring for Children with Drug-Resistant Tuberculosis | 9.7 | 62 | Citations (PDF) |
| 130 | Management of children exposed to multidrug-resistant Mycobacterium tuberculosis | 15.7 | 45 | Citations (PDF) |
| 131 | Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis | 15.7 | 157 | Citations (PDF) |
| 132 | Drug-Resistant Tuberculosis Transmission and Resistance Amplification within Families | 4.0 | 11 | Citations (PDF) |
| 133 | Paediatric use of second-line anti-tuberculosis agents: A review | 2.0 | 55 | Citations (PDF) |
| 134 | Eosinophilia in a returned traveler from West Africa 2010, , 1090-1092 | | 0 | Citations (PDF) |
| 135 | Standardized methods for enhanced quality and comparability of tuberculous meningitis studies | 5.6 | 58 | Citations (PDF) |
